Last updated: 11/07/2018 00:51:36
Phase I/II study of oral topotecan and intravenous paclitaxel in patients with advanced non-small cell lung cancer (phases I and II) and other advanced solid tumors (phase I only)
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Phase I/II study of oral topotecan and intravenous paclitaxel in patients with advanced non-small cell lung cancer (phases I and II) and other advanced solid tumors (phase I only)
Trial description: Phase I/II study of oral topotecan and intravenous paclitaxel in patients with advanced non-small cell lung cancer (phases I and II) and other advanced solid tumors (phase I only)
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Dobbs T, Eckardt J, Fanucchi M, Chrysson N, Beckman R, et al. Oral topotecan (OT) and intravenous paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC): A phase I/II study. PROC AM SOC CLIN ONCOL, 36TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), MAY 20-23 2000, NEW ORLEANS, LA, USA 2000;19/522a (2049).
Eckardt JR, Fanucchi MP, Stewart DJ, Beckman RA, Dobbs TW, et al. A phase I/II study using oral topotecan (OT) with intravenous paclitaxel (P) as a first-line therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC). 9TH World Conference On Lung Cancer, Tokyo, Japan, September 11-15, 2000; Lung Cancer 2000; 29/1 (6).
Eckardt, et al., Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancer. Oncology, 2001, 61(suppl 1):30-34.
Medical condition
Lung Cancer, Non-Small Cell
Product
topotecan
Collaborators
Not applicable
Study date(s)
August 1998 to June 2001
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2001-05-06
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website